Laminin 521 Product List
Species
- Human（7）
Tag
- -（7）
Host
- HEK293（7）
Conjugate
- Unconjugated（7）
Grade
- PG (pre-GMP)（4）
- GMP（2）
- RUO（1）
Low Endotoxin
- No（7）
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Laminin 521 | HOTDMF GMP-LA5H24 | GMP Human Laminin 521 Protein |  Human | HEK293 | $205.00 100ug |   | |||
| Laminin 521 | HOTDMF GMP-LA5H24GA02 | GMP Human Laminin 521 Protein (Liquid) | Human | HEK293 | $490.00 500ug | | |||
| Laminin 521 | HOTDMF LA5-H5261 | Human Laminin 521 Protein, premium grade | Human | HEK293 | $115.00 100ug | | |||
| Laminin 521 | HOT LA5-H5213L | Human Laminin 521 Protein, premium grade (Liquid) | Human | HEK293 | $120.00 100ug | | |||
| Laminin 521 | Human Laminin 521 Protein, premium grade (Flagship Pro) | Human | HEK293 | $120.00 100ug | | ||||
| Laminin 521 | Human Laminin 521 Protein, Research Grade (Flagship) | Human | HEK293 | $40.00 100ug | | ||||
| Laminin 521 | Human Laminin 521 Protein, premium grade (Flagship) | Human | HEK293 | $120.00 100ug | |
You Have Viewed 1-7 Of 7 Results
Asset Licensing Opportunity
Resources
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| HNC042 | HNC-042 | Phase 1 Clinical | Guangzhou Henovcom Bioscience Co Ltd | Influenza A virus infections; Influenza, Human; Influenza B virus infection | Details |
| Oseltamivir/Pimodivir | Phase 1 Clinical | Johnson & Johnson | Influenza A virus infections | Details | |
| Oseltamivir orally disintegrating tablets | HY-100209 | Phase 1 Clinical | Hefei Industrial Pharmaceutical Co Ltd | Influenza A virus infections; Influenza B virus infection | Details |
Marketed Drug Information
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Laninamivir Octanoate Hydrate | CS-8958; R-118958 | Approved | Daiichi Sankyo Co Ltd | Inavir | Japan | Influenza B virus infection; Influenza A virus infections; Influenza, Human | null | 2010-09-10 | Influenza A virus infections; Influenza, Human; Asthma; Influenza B virus infection | Details |
| Zanamivir | GG-167; GR-121167; GR-121167X; 4-Guanidino-Neu5Ac2en | Approved | Glaxosmithkline Plc | 依乐韦, Relenza | United States | Influenza, Human | Glaxosmithkline Plc | 1999-07-26 | Orthomyxoviridae Infections; Diabetes Mellitus, Type 2; Influenza, Human; Arthralgia; Dengue | Details |
| Oseltamivir Phosphate | Ro-64-0796; GS-4104; RO-640796; GS-4104-002; EN-241104; RO-640796/002; GS-4104/002 | Approved | F. Hoffmann-La Roche Ltd | Tamiflu, Hanmi Flu, 达菲 | Switzerland | Influenza, Human | F. Hoffmann-La Roche Ltd | 1999-09-21 | Purpura, Thrombocytopenic, Idiopathic; Influenza A virus infections; Influenza, Human; Influenza in Birds; Obesity; Kidney Failure, Chronic | Details |
| Peramivir Hydrate | BCX-1812; JNJ-2; S-021812; RWJ-270201 | Approved | Biocryst Pharmaceuticals Inc | Peramiflu, Alpivab, 力纬, Rapiacta, Rapivab, Enpiflu Premix | Japan | Influenza, Human | null | 2010-01-13 | Headache; Cough; Myalgia; Fatigue; Influenza A virus infections; Influenza, Human; Fever; Nasal Obstruction; Pharyngitis; Influenza B virus infection | Details |
Customer Reviews